|
Printable version |
From: | "tennyson@caverock.net.nz" <tennyson@caverock.net.nz> |
Date: | Tue, 2 Jul 2002 21:32:55 +0000 |
Hi John, > > >I have to confess to subscribing to this ill fated IPO. >Notice thay have postponed their AGM and share price continues to >dive. More bad tidings to come? Looking for opinions. > > There aren't too many shares to compare Wakefield to on the NZ market, but I found this on the 'aus.invest' newsgroup discussion forum: "'xxxx' runs hospitals, sells medications and provides health diagnostics services. It's (last/listing) report attributed its increased profits to improved margins as much as improved volume, although I am sure that (unlike an insurance company) it wants all those private health insurance punters who have recently served their qualifying period to be putting their bums on its beds :-) So, politics aside, the main long-term concern is if people cease _using_ private health services for some reason." Now as it happens 'xxxx' isn't Wakefield, but it might just as well be as if you substitute WFD for xxxx the whole report rings fairly true. xxxx is in fact MAY as in 'Mayne Group Limited'. In Australia the company that insured all the medical professionals collapsed, leading to the cancellation of much elective surgery. Private hospitals including those run by Mayne, felt the pinch. As a result the MAY share price tanked. I hate to be the gloom merchant, but it is possible that rising medical insurance premiums in NZ will see less of the 40-60 year age group having insurance leading to a permanent diminuition of the number of people seeking elective surgery. Will Southern Cross respond by shuffling a greater percentage of their own insured people off to their own hospitals (using some sort of discount incentive) at the expense of other providers? That would be one way of keeping the critical mass at their own hospitals. But it wouldn't be good, in fact it would be a double blow, for WFD! On this less invasive side of the business, will WFD be receiving more diagnostic tests to run? Will they be able to eek out greater margins on the drugs they sell? I don't know the answer to these questions but they are the sort of question you should ask yourself if you own shares in WFD. I think Philip Robinson did at one stage. Being part of the health system it would be interesting to get his views on WFD as it now stands. WFD is a small company and as such there isn't a huge supply of newsclippings published about it. So doing your homework is a difficult task. The best way to accomplish such research is to contact your local agent on the ground. If Jeff Tracy of Thunderbirds fame had such a task in London he would delegate it to his UK agent, Lady Penelope Creighton Ward. WFD is Wellington based, and here at 'sharechat' we have our own investigator on the ground there, who specialises in small cap shares, Chris 'Creighton' Castle. Perhaps he doesn't have the glamour of the Penelope puppet, but he is also far less likely to have his strings pulled by others too. Calling Chris Carter. Can you throw any local light on the future of WFD? John Wedde has just called you out on a mission. SNOOPY --------------------------------- Message sent by Snoopy e-mail tennyson@caverock.net.nz on Pegasus Mail version 2.55 ---------------------------------- "Dogs have big tongues, so you can bet they don't bite them by accident" ---------------------------------------------------------------------------- To remove yourself from this list, please use the form at http://www.sharechat.co.nz/chat/forum/
References
|